Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

EXPERIMENTAL CONDITION - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (https://rgd.mcw.edu/rgdweb/contact/contactus.html).
Term:disease-inducing agent
go back to main search page
Accession:XCO:0000258 term browser browse the term
Definition:Any phenomenon, chemical or biologic substance, or organism that exerts some force or effect resulting in a deviation from or interruption of the normal structure or function of any body part, organ, or system that is manifested by a characteristic set of symptoms and signs.
Synonyms:exact_synonym: disease inducing agent


show annotations for term's descendants           Sort by:
1,2-dimethylhydrazine term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Colcr1 Colorectal carcinoma resistance QTL 1 IDA 3.0E-4 4.3 RGD PMID:17510081 RGD:1625309 NCBI chr 4:1...29,494,328 JBrowse link
Q Colcr2 Colorectal carcinoma resistance QTL 2 IDA 0.0197 6.57 RGD PMID:17510081 RGD:1625309 NCBI chr15:2,266,368...22,711,984 JBrowse link
Q Colcr3 Colorectal carcinoma resistance QTL 3 IDA 7.0E-6 5.02 RGD PMID:17510081 RGD:1625309 NCBI chr18:2,249,477...22,066,430 JBrowse link
Q Colcr4 Colorectal carcinoma resistance QTL4 IDA 7.0E-4 3.71 RGD PMID:17510081 RGD:1625309 NCBI chr 6:20,338,777...62,613,667 JBrowse link
Q Colcr5 Colorectal carcinoma resistance QTL 5 IDA 9.0E-4 3.18 RGD PMID:17510081 RGD:1625309 NCBI chr 6:122,549,046...137,801,795 JBrowse link
Q Colcr6 Colorectal carcinoma resistance QTL 6 IDA 0.0126 2.9 RGD PMID:17510081 RGD:1625309 NCBI chr15:73,690,518...99,794,247 JBrowse link
Q Colcr7 Colorectal carcinoma resistance QTL 7 IDA 0.0044 3.35 RGD PMID:17510081 RGD:1625309 NCBI chr17:2,115,149...21,881,669 JBrowse link
Q Colcr8 Colorectal carcinoma resistance QTL 8 IDA 0.0014 3.1 RGD PMID:17510081 RGD:1625309 NCBI chr18:22,066,242...52,293,055 JBrowse link
Q Colcr9 Colorectal carcinoma resistance QTL 9 IDA 0.0024 2.97 RGD PMID:17510081 RGD:1625309 NCBI chr20:1,530,655...46,530,655 JBrowse link
Q Colcs1 Colorectal carcinoma susceptibility QTL 1 IDA 0.0055 2.99 RGD PMID:17510081 RGD:1625309 NCBI chr 5:121,846,814...166,846,814 JBrowse link
2-acetamidofluorene term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar1 Hepatocarcinoma resistance QTL 1 IDA 1.0E-4 3.4 RGD PMID:10493520 RGD:619598 NCBI chr10:6,154,182...15,990,232 JBrowse link
Q Hcar10 Hepatocarcinoma resistance QTL 10 IDA 2.9 RGD PMID:12154055 RGD:629566 NCBI chr 8:40,713,066...82,925,667 JBrowse link
Q Hcar11 Hepatocarcinoma resistance QTL 11 IDA 4.4 RGD PMID:12154055 RGD:629566 NCBI chr 6:82,523,650...110,548,006 JBrowse link
Q Hcar12 Hepatocarcinoma resistance QTL 12 IDA 2.6 RGD PMID:12154055 RGD:629566 NCBI chr 3:29,463,235...118,376,539 JBrowse link
Q Hcar13 Hepatocarcinoma resistance QTL 13 IDA 4.3 RGD PMID:15185337 RGD:737884 NCBI chr 4:1...32,584,199 JBrowse link
Q Hcar14 Hepatocarcinoma resistance QTL 14 IDA 4.3 RGD PMID:15185337 RGD:737884 NCBI chr18:51,464,733...83,218,561 JBrowse link
Q Hcar2 Hepatocarcinoma resistance QTL 2 IDA 3.0E-4 3.1 RGD PMID:10493520 RGD:619598 NCBI chr 4:78,878,504...123,878,504 JBrowse link
Q Hcar3 Hepatocarcinoma resistance QTL 3 IDA 5.0E-4 2.9 RGD PMID:10493520 RGD:619598 NCBI chr 8:54,237,644...99,103,503 JBrowse link
Q Hcar9 Hepatocarcinoma resistance QTL 9 IDA 3.7 RGD PMID:12154055 RGD:629566 NCBI chr 4:109,866,907...167,139,601 JBrowse link
Q Hcas1 Hepatocarcinoma susceptibility QTL 1 IDA 0.001 3.9 RGD PMID:10493520 RGD:619598 NCBI chr 7:91,412,594...129,807,172 JBrowse link
Q Hcas2 Hepatocarcinoma susceptibility QTL 2 IDA 1.0E-4 3.0 RGD PMID:10493520 RGD:619598 NCBI chr 1:5,925,874...115,540,829 JBrowse link
Q Hcas3 Hepatocarcinoma susceptibility QTL 3 IDA 4.9 RGD PMID:12154055 RGD:629566 NCBI chr 1:144,267,353...222,987,745 JBrowse link
Q Hcas4 Hepatocarcinoma susceptibility QTL 4 IDA 4.43 RGD PMID:12154055 RGD:629566 NCBI chr16:4,227,609...46,975,965 JBrowse link
Q Hcas5 Hepatocarcinoma susceptibility QTL 5 IDA 3.12 RGD PMID:15185337 RGD:737884 NCBI chr 1:176,426,412...257,976,495 JBrowse link
Q Hcas6 Hepatocarcinoma susceptibility QTL 6 IDA 2.93 RGD PMID:15185337 RGD:737884 NCBI chr14:39,057,237...83,368,335 JBrowse link
Q Hcas7 Hepatocarcinoma susceptibility QTL 7 IDA 2.91 RGD PMID:15185337 RGD:737884 NCBI chr15:2,266,368...46,921,453 JBrowse link
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 IDA 0.001 3.85 RGD PMID:12672032 RGD:629574 NCBI chr 7:34,293,282...79,293,282 JBrowse link
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 IDA 5.0E-4 2.9 RGD PMID:12672032 RGD:629574 NCBI chr 1:233,948,574...260,522,016 JBrowse link
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 IDA 2.94 RGD PMID:15185337 RGD:737884 NCBI chr 2:1...41,244,106 JBrowse link
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 IDA 3.64 RGD PMID:15185337 RGD:737884 NCBI chr13:1...42,356,786 JBrowse link
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 IDA 3.29 RGD PMID:15185337 RGD:737884 NCBI chr13:59,874,408...85,581,182 JBrowse link
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 IDA 3.3 RGD PMID:15185337 RGD:737884 NCBI chr13:74,862,117...85,581,182 JBrowse link
3-methyl-4'-dimethylaminoazobenzene term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA 0.05 RGD PMID:15771619 RGD:1358145 NCBI chr 1:153,136,852...260,522,016 JBrowse link
4-nitroquinoline N-oxide term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcas10 Tongue tumor susceptibility QTL 10 IDA 3.12 RGD PMID:11429048 RGD:634723 NCBI chr10:31,297,439...76,297,439 JBrowse link
Q Tcas11 Tongue tumor susceptibility QTL 11 IDA 4.12 RGD PMID:16527513 RGD:1578522 NCBI chr 5:46,711,509...161,317,411 JBrowse link
Q Tcas2 Tongue tumor susceptibility QTL 2 IDA 4.93 RGD PMID:11429048 RGD:634723 NCBI chr 1:192,485,903...199,050,587 JBrowse link
Q Tcas3 Tongue tumor susceptibility QTL 3 IDA 6.88 RGD PMID:11429048 RGD:634723 NCBI chr 4:10,814,170...91,360,527 JBrowse link
Q Tcas4 Tongue tumor susceptibility QTL 4 IDA 7.29 RGD PMID:11429048 RGD:634723 NCBI chr14:17,622,561...42,337,007 JBrowse link
Q Tcas5 Tongue tumor susceptibility QTL 5 IDA 10.04 RGD PMID:11429048 RGD:634723 NCBI chr19:9,977,753...39,654,489 JBrowse link
Q Tcas6 Tongue tumor susceptibility QTL 6 IDA 6.85 RGD PMID:11429048 RGD:634723 NCBI chr 1:92,948,896...144,267,916 JBrowse link
Q Tcas7 Tongue tumor susceptibility QTL 7 IDA 0.001 RGD PMID:15876484 RGD:1358147 NCBI chr19:24,817,978...39,654,489 JBrowse link
Q Tcas8 Tongue tumor susceptibility QTL 8 IDA 3.47 RGD PMID:11429048 RGD:634723
Q Tcas9 Tongue tumor susceptibility QTL 9 IDA 3.29 RGD PMID:11429048 RGD:634723 NCBI chr 6:1...37,618,905 JBrowse link
7,12-dimethyltetraphene term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Mamtr1 Mammary tumor resistance QTL 1 IDA 1.0E-4 RGD PMID:12844486 RGD:631852 NCBI chr 5:12,789,751...113,558,310 JBrowse link
Q Mamtr2 Mammary tumor resistance QTL 2 IDA 1.0E-4 RGD PMID:14522903 RGD:724790 NCBI chr 2:7,887,772...12,654,247 JBrowse link
Q Mamtr3 Mammary tumor resistance QTL 3 IDA 1.0E-4 RGD PMID:14522903 RGD:724790 NCBI chr 2:32,373,770...43,665,178 JBrowse link
Q Mamtr4 Mammary tumor resistance QTL 4 IDA 3.0E-4 RGD PMID:14522903 RGD:724790 NCBI chr 2:16,491,740...61,491,740 JBrowse link
Q Mamtr5 Mammary tumor resistance QTL 5 IDA 65mg/kg body mass RGD PMID:17230524 RGD:1599390 NCBI chr 5:18,873,947...63,873,947 JBrowse link
Q Mamtr6 Mammary tumor resistance QTL 6 IDA 65mg/kg body mass RGD PMID:17230524 RGD:1599390 NCBI chr18:19,278,901...83,218,561 JBrowse link
Q Mamtr7 Mammary tumor resistance QTL 7 IDA 0.003 65mg/kg body mass RGD PMID:19052818 RGD:2302423 NCBI chr10:9,658,275...104,670,812 JBrowse link
Q Mamtr8 Mammary tumor resistance QTL 8 IDA 0.001 65mg/ml body mass RGD PMID:19052818 RGD:2302423 NCBI chr18:31,359,408...83,218,561 JBrowse link
Q Mcs1 Mammary carcinoma susceptibility QTL 1 IDA 4.4 RGD PMID:8168109 RGD:61080 NCBI chr 2:7,887,772...23,319,447 JBrowse link
Q Mcs12 Mammary carcinoma susceptibility QTL 12 IDA 1.0E-4 RGD PMID:16266982 RGD:1559294 NCBI chr 5:58,973,449...60,051,321 JBrowse link
Q Mcs13 Mammary carcinoma susceptibility QTL 13 IDA 1.0E-4 RGD PMID:16266982 RGD:1559294 NCBI chr 5:63,190,890...69,927,503 JBrowse link
Q Mcs14 Mammary carcinoma susceptibility QTL 14 IDA 1.0E-4 RGD PMID:16266982 RGD:1559294 NCBI chr 5:76,369,776...80,813,390 JBrowse link
Q Mcs15 Mammary carcinoma susceptibility QTL 15 IDA 4.5 RGD PMID:16568087 RGD:1581951 NCBI chr10:85,565,469...103,884,409 JBrowse link
Q Mcs16 Mammary carcinoma susceptibility QTL 16 IDA 2.4 RGD PMID:16596452 RGD:1599317 NCBI chr 1:2,244,390...43,433,040 JBrowse link
Q Mcs17 Mammary carcinoma susceptibility QTL 17 IDA 3.0 RGD PMID:16596452 RGD:1599317 NCBI chr 1:197,670,404...242,670,404 JBrowse link
Q Mcs18 Mammary carcinoma susceptibility QTL 18 IDA 2.6 RGD PMID:16596452 RGD:1599317 NCBI chr 2:7,887,772...42,804,738 JBrowse link
Q Mcs19 Mammary carcinoma susceptibility QTL 19 IDA 2.5 RGD PMID:16596452 RGD:1599317 NCBI chr 5:99,485,997...103,690,167 JBrowse link
Q Mcs2 Mammary carcinoma susceptibility QTL 2 IDA 3.38 RGD PMID:9584103 RGD:61081 NCBI chr 7:19,032,807...35,526,300 JBrowse link
Q Mcs20 Mammary carcinoma susceptibility QTL 20 IDA 3.0 RGD PMID:16596452 RGD:1599317 NCBI chr 9:13,533,770...42,791,750 JBrowse link
Q Mcs21 Mammary carcinoma susceptibility QTL 21 IDA 3.0 RGD PMID:16596452 RGD:1599317 NCBI chr10:28,875,650...52,200,160 JBrowse link
Q Mcs22 Mammary carcinoma susceptibility QTL 22 IDA 3.3 RGD PMID:16596452 RGD:1599317 NCBI chr18:52,539,763...63,933,058 JBrowse link
Q Mcs23 Mammary carcinoma susceptibility QTL 23 IDA RGD PMID:17404222 RGD:1601189
Q Mcs24 Mammary carcinoma susceptibility QTL 24 IDA RGD PMID:17404222 RGD:1601189 NCBI chr 5:64,719,390...109,719,390 JBrowse link
Q Mcs25 Mammary carcinoma susceptibility QTL 25 IDA 1.0E-4 65mg/kg body weight RGD PMID:20737482 RGD:4143380 NCBI chr 6:10,894,415...110,548,006 JBrowse link
Q Mcs26 Mammary carcinoma susceptibility QTL 26 IDA 1.0E-4 65mg/kg body weight RGD PMID:20737482 RGD:4143380 NCBI chr 6:106,752,656...132,339,866 JBrowse link
Q Mcs27 Mammary carcinoma susceptibility QTL 27 IDA 1.0E-4 65mg/kg body weight RGD PMID:20737482 RGD:4143380 NCBI chr13:43,437,904...47,841,255 JBrowse link
Q Mcs28 Mammary carcinoma susceptibility QTL 28 IDA RGD PMID:21205740 RGD:5684388 NCBI chr 5:77,743,239...78,039,084 JBrowse link
Q Mcs29 Mammary carcinoma susceptibility QTL 29 IDA RGD PMID:21205740 RGD:5684388 NCBI chr 5:77,816,155...77,988,860 JBrowse link
Q Mcs3 Mammary carcinoma susceptibility QTL 3 IDA 2.15 65mg/kg body weight RGD PMID:9584103 RGD:61081 NCBI chr 1:102,268,556...147,268,556 JBrowse link
Q Mcs4 Mammary carcinoma susceptibility QTL 4 IDA 1.1 65mg/kg body weight RGD PMID:9584103 RGD:61081 NCBI chr 8:16,290,444...61,290,444 JBrowse link
Q Mcs5 Mammary carcinoma susceptibility QTL 5 IDA 10.51 RGD PMID:11139513 RGD:62417 NCBI chr 5:55,805,606...132,207,589 JBrowse link
Q Mcs6 Mammary carcinoma susceptibility QTL 6 IDA 2.29 RGD PMID:11139513 RGD:62417 NCBI chr 7:26,737,401...63,902,784 JBrowse link
Q Mcs7 Mammary carcinoma susceptibility QTL 7 IDA 2.38 RGD PMID:11139513 RGD:62417 NCBI chr10:72,224,939...107,211,142 JBrowse link
Q Mcs8 Mammary carcinoma susceptibility QTL 8 IDA 4.28 RGD PMID:11139513 RGD:62417 NCBI chr14:3,813,074...24,531,477 JBrowse link
Q Mcsm1 Mammary carcinoma susceptibility modifier QTL 1 IDA RGD PMID:11139513 RGD:62417 NCBI chr 6:58,632,962...103,632,962 JBrowse link
aurothiopropanol sulfonate term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Iresp1 Immunoglobin response QTL1 IDA 8.3 RGD PMID:10898507 RGD:619646 NCBI chr20:9,039,719...13,461,775 JBrowse link
Q Iresp2 Immunoglobin response QTL2 IDA 6.3 RGD PMID:10898507 RGD:619646 NCBI chr10:22,918,268...36,400,810 JBrowse link
Q Iresp3 Immunoglobin response QTL3 IDA 16.2 RGD PMID:10898507 RGD:619646 NCBI chr 9:2,745,799...5,857,951 JBrowse link
collagenase-solubilized rat glomerular basement membrane term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Glom27 Glomerulus QTL 27 IDA 3.9 RGD PMID:22445570 RGD:7207870 NCBI chr13:21,120,177...109,350,286 JBrowse link
controlled 3-methyl-4'-dimethylaminoazobenzene content diet term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar4 Hepatocarcinoma resistance QTL 4 IDA 4.6 RGD PMID:10850431 RGD:619609 NCBI chr 1:193,422,268...214,537,671 JBrowse link
Q Hcar5 Hepatocarcinoma resistance QTL 5 IDA 8.0 RGD PMID:10850431 RGD:619609 NCBI chr 1:214,537,555...226,660,468 JBrowse link
Q Hcar6 Hepatocarcinoma resistance QTL 6 IDA RGD PMID:10850431 RGD:619609
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA 7.8 RGD PMID:10850431 RGD:619609 NCBI chr 4:70,808,386...115,808,386 JBrowse link
Q Hcar8 Hepatocarcinoma resistance QTL 8 IDA 5.8 RGD PMID:10850431 RGD:619609 NCBI chr 4:123,143,783...168,143,783 JBrowse link
controlled 4-nitroquinoline N-oxide content drinking water term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcas1 Tongue tumor susceptibility QTL 1 IDA 6.08 RGD PMID:9563479 RGD:61091 NCBI chr19:2,316,121...47,316,121 JBrowse link
Q Tcat1 Tongue tumor resistance QTL 1 IDA 3.3 RGD PMID:9563479 RGD:61091 NCBI chr 1:99,267,916...144,267,916 JBrowse link
controlled N-methyl-N'-nitro-N-nitrosoguanidine content drinking water term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Gcr1 Gastric cancer resistance QTL 1 IDA 2.7 RGD PMID:10706129 RGD:69698 NCBI chr 4:120,260,281...147,278,687 JBrowse link
Q Gcr2 Gastric cancer resistance QTL 2 IDA 2.6 RGD PMID:10706129 RGD:69698 NCBI chr 3:8,658,162...27,494,778 JBrowse link
Q Gcr3 Gastric cancer resistance QTL 3 IDA 2.3 RGD PMID:10706129 RGD:69698 NCBI chr16:17,696,791...82,635,055 JBrowse link
Q Gcs1 Gastric cancer susceptibility QTL1 IDA 3.8 RGD PMID:10706129 RGD:69698 NCBI chr15:76,306,099...101,769,107 JBrowse link
controlled N-propyl-N-nitrosourea content drinking water term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tls1 T-lymphoma susceptibility QTL 1 IDA 0.001 0.0 RGD PMID:10360666 RGD:619600 NCBI chr 5:90,450,144...135,450,144 JBrowse link
Q Tls2 T-lymphoma susceptibility QTL 2 IDA 0.001 0.0 RGD PMID:10360666 RGD:619600 NCBI chr 7:82,111,382...132,099,989 JBrowse link
Q Tls3 T-lymphoma susceptibility QTL 3 IDA 1.0E-4 0.0 RGD PMID:10360666 RGD:619600 NCBI chr10:27,587,226...96,099,902 JBrowse link
Herpes simplex virus type 1 term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Bw143 Body weight QTL 143 IDA 7.3 RGD PMID:22761571 RGD:7240516 NCBI chr 4:34,430,484...82,490,359 JBrowse link
Q Bw144 Body weight QTL 144 IDA 16.0 RGD PMID:22761571 RGD:7240516 NCBI chr 4:22,710,685...34,430,484 JBrowse link
Q Bw145 Body weight QTL 145 IDA 2.2 RGD PMID:22761571 RGD:7240516 NCBI chr10:41,944,526...78,307,017 JBrowse link
Q Vie1 Viral induced encephalitis QTL 1 IDA 26.4 RGD PMID:22761571 RGD:7240516 NCBI chr 4:34,430,484...82,490,359 JBrowse link
Q Vie2 Viral induced encephalitis QTL 2 IDA 4.1 RGD PMID:22761571 RGD:7240516 NCBI chr 3:145,956,084...169,034,231 JBrowse link
Q Vie3 Viral induced encephalitis QTL 3 IDA 2.6 RGD PMID:22761571 RGD:7240516 NCBI chr 6:96,833,997...140,994,061 JBrowse link
Q Vie4 Viral induced encephalitis QTL 4 IDA 7.3 RGD PMID:22761571 RGD:7240516 NCBI chr 4:62,933,508...82,490,359 JBrowse link
Q Vie5 Viral induced encephalitis QTL 5 IDA 25.3 RGD PMID:22761571 RGD:7240516 NCBI chr 4:34,430,484...82,490,359 JBrowse link
Kilham rat virus term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Iddm20 Insulin dependent diabetes mellitus QTL 20 IDA 3.7 RGD PMID:15793267 RGD:1358924 NCBI chr17:13,986,773...21,975,515 JBrowse link
Q Iddm37 Insulin dependent diabetes mellitus QTL 37 IDA 6.0 RGD PMID:19720792 RGD:2313174 NCBI chr20:1,527,842...46,527,842 JBrowse link
N-methyl-N-nitrosourea term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Mcs30 Mammary carcinoma susceptibility QTL 30 IDA 8.62 RGD PMID:24023717 RGD:7327193 NCBI chr12:797,729...8,525,593 JBrowse link
N-nitrosodiethylamine term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar1 Hepatocarcinoma resistance QTL 1 IDA 1.0E-4 3.4 RGD PMID:10493520 RGD:619598 NCBI chr10:6,154,182...15,990,232 JBrowse link
Q Hcar10 Hepatocarcinoma resistance QTL 10 IDA 2.9 RGD PMID:12154055 RGD:629566 NCBI chr 8:40,713,066...82,925,667 JBrowse link
Q Hcar11 Hepatocarcinoma resistance QTL 11 IDA 4.4 RGD PMID:12154055 RGD:629566 NCBI chr 6:82,523,650...110,548,006 JBrowse link
Q Hcar12 Hepatocarcinoma resistance QTL 12 IDA 2.6 RGD PMID:12154055 RGD:629566 NCBI chr 3:29,463,235...118,376,539 JBrowse link
Q Hcar13 Hepatocarcinoma resistance QTL 13 IDA 4.3 RGD PMID:15185337 RGD:737884 NCBI chr 4:1...32,584,199 JBrowse link
Q Hcar14 Hepatocarcinoma resistance QTL 14 IDA 4.3 RGD PMID:15185337 RGD:737884 NCBI chr18:51,464,733...83,218,561 JBrowse link
Q Hcar2 Hepatocarcinoma resistance QTL 2 IDA 3.0E-4 3.1 RGD PMID:10493520 RGD:619598 NCBI chr 4:78,878,504...123,878,504 JBrowse link
Q Hcar3 Hepatocarcinoma resistance QTL 3 IDA 5.0E-4 2.9 RGD PMID:10493520 RGD:619598 NCBI chr 8:54,237,644...99,103,503 JBrowse link
Q Hcar9 Hepatocarcinoma resistance QTL 9 IDA 3.7 RGD PMID:12154055 RGD:629566 NCBI chr 4:109,866,907...167,139,601 JBrowse link
Q Hcas1 Hepatocarcinoma susceptibility QTL 1 IDA 0.001 3.9 RGD PMID:10493520 RGD:619598 NCBI chr 7:91,412,594...129,807,172 JBrowse link
Q Hcas2 Hepatocarcinoma susceptibility QTL 2 IDA 1.0E-4 3.0 RGD PMID:10493520 RGD:619598 NCBI chr 1:5,925,874...115,540,829 JBrowse link
Q Hcas3 Hepatocarcinoma susceptibility QTL 3 IDA 4.9 RGD PMID:12154055 RGD:629566 NCBI chr 1:144,267,353...222,987,745 JBrowse link
Q Hcas4 Hepatocarcinoma susceptibility QTL 4 IDA 4.43 RGD PMID:12154055 RGD:629566 NCBI chr16:4,227,609...46,975,965 JBrowse link
Q Hcas5 Hepatocarcinoma susceptibility QTL 5 IDA 3.12 RGD PMID:15185337 RGD:737884 NCBI chr 1:176,426,412...257,976,495 JBrowse link
Q Hcas6 Hepatocarcinoma susceptibility QTL 6 IDA 2.93 RGD PMID:15185337 RGD:737884 NCBI chr14:39,057,237...83,368,335 JBrowse link
Q Hcas7 Hepatocarcinoma susceptibility QTL 7 IDA 2.91 RGD PMID:15185337 RGD:737884 NCBI chr15:2,266,368...46,921,453 JBrowse link
Q Hcas8 Hepatocarcinoma susceptibility QTL 8 IDA RGD PMID:17079458 RGD:1599590 NCBI chr16:1...22,477,621 JBrowse link
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 IDA 0.001 3.85 RGD PMID:12672032 RGD:629574 NCBI chr 7:34,293,282...79,293,282 JBrowse link
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 IDA 5.0E-4 2.9 RGD PMID:12672032 RGD:629574 NCBI chr 1:233,948,574...260,522,016 JBrowse link
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 IDA 2.94 RGD PMID:15185337 RGD:737884 NCBI chr 2:1...41,244,106 JBrowse link
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 IDA 3.64 RGD PMID:15185337 RGD:737884 NCBI chr13:1...42,356,786 JBrowse link
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 IDA 3.29 RGD PMID:15185337 RGD:737884 NCBI chr13:59,874,408...85,581,182 JBrowse link
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 IDA 3.3 RGD PMID:15185337 RGD:737884 NCBI chr13:74,862,117...85,581,182 JBrowse link
peptidoglycan-polysaccharide term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Aia10 Adjuvant induced arthritis QTL 10 IDA 3.41 RGD PMID:19526527 RGD:2316974 NCBI chr15:75,788,062...101,769,107 JBrowse link
Q Aia11 Adjuvant induced arthritis QTL 11 IDA 4.06 RGD PMID:19526527 RGD:2316974 NCBI chr17:60,781,426...86,533,673 JBrowse link
Q Aia12 Adjuvant induced arthritis QTL 12 IDA 4.24 RGD PMID:19526527 RGD:2316974 NCBI chr17:38,281,509...83,281,509 JBrowse link
Q Aia13 Adjuvant induced arthritis QTL 13 IDA 2.9 RGD PMID:19526527 RGD:2316974 NCBI chr 2:76,539,322...77,991,361 JBrowse link
Q Aia14 Adjuvant induced arthritis QTL 14 IDA 3.29 RGD PMID:19526527 RGD:2316974
Q Aia15 Adjuvant induced arthritis QTL 15 IDA 2.46 RGD PMID:19526527 RGD:2316974 NCBI chr 7:17,004,598...62,004,598 JBrowse link
Q Aia16 Adjuvant induced arthritis QTL 16 IDA 2.71 RGD PMID:19526527 RGD:2316974 NCBI chr 7:59,238,038...104,238,038 JBrowse link
Q Aia17 Adjuvant induced arthritis QTL 17 IDA 2.13 RGD PMID:19526527 RGD:2316974 NCBI chr 7:81,737,938...126,737,938 JBrowse link
Q Aia18 Adjuvant induced arthritis QTL 18 IDA 2.42 RGD PMID:19526527 RGD:2316974 NCBI chr 8:8,736,635...53,736,635 JBrowse link
Q Aia19 Adjuvant induced arthritis QTL 19 IDA 2.98 RGD PMID:19526527 RGD:2316974 NCBI chr10:66,978,955...107,211,142 JBrowse link
Q Aia20 Adjuvant induced arthritis QTL 20 IDA 3.38 RGD PMID:19526527 RGD:2316974 NCBI chr10:37,565,079...82,565,079 JBrowse link
Q Aia21 Adjuvant induced arthritis QTL 21 IDA 2.75 RGD PMID:19526527 RGD:2316974 NCBI chr13:9,831,541...54,831,541 JBrowse link
Q Aia22 Adjuvant induced arthritis QTL 22 IDA 2.29 RGD PMID:19526527 RGD:2316974 NCBI chr13:1...34,266,636 JBrowse link
Q Aia23 Adjuvant induced arthritis QTL 23 IDA 2.3 RGD PMID:19526527 RGD:2316974 NCBI chr13:11,766,535...32,331,607 JBrowse link
Q Aia24 Adjuvant induced arthritis QTL 24 IDA 2.06 RGD PMID:19526527 RGD:2316974 NCBI chr15:52,847,908...73,690,657 JBrowse link
Q Aia25 Adjuvant induced arthritis QTL 25 IDA 2.69 RGD PMID:19526527 RGD:2316974 NCBI chr17:50,909,196...60,781,426 JBrowse link
Q Aia26 Adjuvant induced arthritis QTL 26 IDA 3.22 RGD PMID:19526527 RGD:2316974 NCBI chr17:38,281,509...83,281,509 JBrowse link
Q Aia27 Adjuvant induced arthritis QTL 27 IDA 2.83 RGD PMID:19526527 RGD:2316974 NCBI chr20:2,892,597...26,381,954 JBrowse link
Q Aia6 Adjuvant induced arthritis QTL 6 IDA 4.31 RGD PMID:19526527 RGD:2316974 NCBI chr10:66,978,955...107,211,142 JBrowse link
Q Aia7 Adjuvant induced arthritis QTL 7 IDA 3.82 RGD PMID:19526527 RGD:2316974 NCBI chr10:37,565,079...82,565,079 JBrowse link
Q Aia8 Adjuvant induced arthritis QTL 8 IDA 3.9700000286102295 RGD PMID:19526527 RGD:2316974 NCBI chr13:9,831,541...54,831,541 JBrowse link
Q Aia9 Adjuvant induced arthritis QTL 9 IDA 4.62 RGD PMID:19526527 RGD:2316974 NCBI chr13:11,766,535...32,331,607 JBrowse link
Q Ginf1 Gastrointestinal inflammation QTL 1 IDA 0.005 3.52 RGD PMID:19526527 RGD:2316974 NCBI chr 8:4,705,810...49,705,810 JBrowse link
Q Ginf2 Gastrointestinal inflammation QTL 2 IDA 0.005 3.21 RGD PMID:19526527 RGD:2316974 NCBI chr 8:4,705,810...49,705,810 JBrowse link
Q Ginf3 Gastrointestinal inflammation QTL 3 IDA 0.005 2.89 RGD PMID:19526527 RGD:2316974 NCBI chr17:49,920,154...86,533,673 JBrowse link
Q Livw3 Liver weight QTL 3 IDA 0.01 2.43 RGD PMID:19526527 RGD:2316974 NCBI chr 8:4,705,810...49,705,810 JBrowse link
Q Wbc3 White blood cell count QTL 3 IDA 0.01 2.51 RGD PMID:19526527 RGD:2316974 NCBI chr 5:111,236,572...156,236,572 JBrowse link
Q Wbc4 White blood cell count QTL 4 IDA 0.01 RGD PMID:19526527 RGD:2316974
Q Wbc5 White blood cell count QTL 5 IDA 0.005 3.21 RGD PMID:19526527 RGD:2316974 NCBI chr 8:16,994,642...61,994,642 JBrowse link
pristane term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Apr1 Acute phase response QTL 1 IDA 6.1 RGD PMID:11817600 RGD:629561 NCBI chr12:19,144,362...46,669,029 JBrowse link
Q Apr2 Acute phase response QTL 2 IDA 3.7 RGD PMID:11817600 RGD:629561 NCBI chr 5:135,927,956...166,875,058 JBrowse link
Q Apr3 Acute phase response QTL 3 IDA 3.9 RGD PMID:11817600 RGD:629561 NCBI chr10:15,275,955...60,275,955 JBrowse link
Q Apr4 Acute phase response QTL 4 IDA 6.0 RGD PMID:11817600 RGD:629561 NCBI chr12:1,172,005...46,172,005 JBrowse link
Q Apr5 Acute phase response QTL 5 IDA 6.7 RGD PMID:11817600 RGD:629561 NCBI chr12:1...44,503,507 JBrowse link
Q Apr6 Acute phase response QTL 6 IDA 3.7 RGD PMID:11817600 RGD:629561 NCBI chr14:1...41,131,407 JBrowse link
Q Oia7 Oil induced arthritis QTL 7 IDA 1.0E-4 RGD PMID:12915467 RGD:730281 NCBI chr 4:156,050,654...157,232,313 JBrowse link
Q Pia1 Pristane induced arthritis QTL 1 IDA RGD PMID:9843218 RGD:61089
Q Pia10 Pristane induced arthritis QTL 10 IDA 0.01 RGD PMID:12209529 RGD:629569 NCBI chr10:23,444,813...104,060,283 JBrowse link
Q Pia11 Pristane induced arthritis QTL 11 IDA 5.3 RGD PMID:12111642 RGD:631225 NCBI chr 1:136,830,018...181,830,018 JBrowse link
Q Pia12 Pristane induced arthritis QTL 12 IDA 8.9 RGD PMID:12111642 RGD:631225 NCBI chr12:20,259,417...23,672,083 JBrowse link
Q Pia13 Pristane induced arthritis QTL 13 IDA 3.3 RGD PMID:12111642 RGD:631225 NCBI chr14:40,793,460...98,037,301 JBrowse link
Q Pia14 Pristane induced arthritis QTL 14 IDA 4.4 RGD PMID:12111642 RGD:631225 NCBI chr16:55,711,087...83,402,471 JBrowse link
Q Pia15 Pristane induced arthritis QTL 15 IDA 3.1 RGD PMID:12817024 RGD:631850 NCBI chr10:1...24,158,324 JBrowse link
Q Pia16 Pristane induced arthritis QTL 16 IDA 3.9 RGD PMID:12817024 RGD:631850 NCBI chr 6:45,790,088...104,200,226 JBrowse link
Q Pia17 Pristane induced arthritis QTL 17 IDA 4.7 RGD PMID:12817024 RGD:631850 NCBI chr 7:73,829,340...130,221,005 JBrowse link
Q Pia18 Pristane induced arthritis QTL 18 IDA 4.0 RGD PMID:12817024 RGD:631850 NCBI chr 8:75,311,938...82,925,521 JBrowse link
Q Pia19 Pristane induced arthritis QTL 19 IDA 3.4 RGD PMID:12817024 RGD:631850 NCBI chr18:73,997,140...79,532,029 JBrowse link
Q Pia2 Pristane induced arthritis QTL 2 IDA 3.9 RGD PMID:9843218 RGD:61089 NCBI chr 4:21,333,343...62,278,020 JBrowse link
Q Pia20 Pristane induced arthritis QTL 20 IDA 3.55 RGD PMID:14624754 RGD:730280 NCBI chr14:9,088,978...39,057,237 JBrowse link
Q Pia21 Pristane induced arthritis QTL 21 IDA 4.8 RGD PMID:12817024 RGD:631850 NCBI chr20:3,621,656...4,606,812 JBrowse link
Q Pia22 Pristane induced arthritis QTL 22 IDA 53.1 RGD PMID:12817024 RGD:631850 NCBI chr12:1...44,465,750 JBrowse link
Q Pia23 Pristane induced arthritis QTL 23 IDA 5.3 RGD PMID:12817024 RGD:631850 NCBI chr 4:131,730,738...167,139,601 JBrowse link
Q Pia24 Pristane induced arthritis QTL 24 IDA RGD PMID:14611807 RGD:728382 NCBI chr 6:112,636,280...140,994,061 JBrowse link
Q Pia25 Pristane induced arthritis QTL 25 IDA RGD PMID:15944295 RGD:1359065 NCBI chr10:96,120,911...104,060,283 JBrowse link
Q Pia26 Pristane induced arthritis QTL 26 IDA RGD PMID:15944295 RGD:1359065 NCBI chr10:31,224,026...75,632,053 JBrowse link
Q Pia27 Pristane induced arthritis QTL 27 IDA 0.001 18.6 RGD PMID:14674011 RGD:2302026 NCBI chr11:82,566,545...83,440,803 JBrowse link
Q Pia28 Pristane induced arthritis QTL 28 IDA 0.001 5.3 RGD PMID:14674011 RGD:2302026 NCBI chr 4:73,630,210...118,630,210 JBrowse link
Q Pia29 Pristane induced arthritis QTL 29 IDA 0.001 3.6 RGD PMID:14674011 RGD:2302026 NCBI chr16:21,735,975...66,735,975 JBrowse link
Q Pia3 Pristane induced arthritis QTL 3 IDA 4.5 RGD PMID:9843218 RGD:61089 NCBI chr 6:94,968,928...137,848,904 JBrowse link
Q Pia30 Pristane induced arthritis QTL 30 IDA 0.001 3.5 RGD PMID:14674011 RGD:2302026 NCBI chr 3:27,936,919...72,936,919 JBrowse link
Q Pia31 Pristane induced arthritis QTL 31 IDA 0.001 5.5 RGD PMID:14674011 RGD:2302026 NCBI chr 1:10,992,065...55,992,065 JBrowse link
Q Pia32 Pristane induced arthritis QTL 32 IDA 0.001 5.1 RGD PMID:14674011 RGD:2302026 NCBI chr 4:105,789,505...150,789,505 JBrowse link
Q Pia33 Pristane induced arthritis QTL 33 IDA 0.001 5.0 RGD PMID:14674011 RGD:2302026
Q Pia34 Pristane induced arthritis QTL 34 IDA 0.001 5.8 RGD PMID:14674011 RGD:2302026
Q Pia35 Pristane induced arthritis QTL 35 IDA 0.001 3.8 RGD PMID:14674011 RGD:2302026 NCBI chr 1:216,255,568...260,522,016 JBrowse link
Q Pia36 Pristane induced arthritis QTL 36 IDA 0.001 3.8 RGD PMID:14674011 RGD:2302026 NCBI chr 1:43,333,002...88,333,002 JBrowse link
Q Pia37 Pristane induced arthritis QTL 37 IDA 0.001 6.1 RGD PMID:14674011 RGD:2302026 NCBI chr12:13,198,157...46,669,029 JBrowse link
Q Pia38 Pristane induced arthritis QTL 38 IDA 0.001 3.5 RGD PMID:14674011 RGD:2302026 NCBI chr12:1...44,503,507 JBrowse link
Q Pia39 Pristane induced arthritis QTL 39 IDA 0.001 4.9 RGD PMID:14674011 RGD:2302026 NCBI chr14:8,267,090...53,267,090 JBrowse link
Q Pia4 Pristane induced arthritis QTL 4 IDA 8.4 RGD PMID:9843218 RGD:61089 NCBI chr12:13,635,523...30,827,399 JBrowse link
Q Pia40 Pristane induced arthritis QTL 40 IDA 1.0E-4 RGD PMID:19180494 RGD:2306838 NCBI chr20:1,527,959...5,304,575 JBrowse link
Q Pia41 Pristane induced arthritis QTL 41 IDA RGD PMID:20072140 RGD:6892695 NCBI chr 1:178,810,256...180,814,005 JBrowse link
Q Pia42 Pristane induced arthritis QTL 42 IDA RGD PMID:17329308 RGD:1600250 NCBI chr12:19,610,870...42,828,880 JBrowse link
Q Pia5 Pristane induced arthritis QTL 5 IDA 4.5 RGD PMID:9843218 RGD:61089 NCBI chr 4:62,277,855...128,289,560 JBrowse link
Q Pia6 Pristane induced arthritis QTL 6 IDA 4.9 RGD PMID:9843218 RGD:61089 NCBI chr14:18,631,345...42,337,007 JBrowse link
Q Pia7 Pristane induced arthritis QTL 7 IDA 4.3 RGD PMID:11090241 RGD:629570 NCBI chr 4:131,730,738...167,139,601 JBrowse link
Q Pia8 Pristane induced arthritis QTL 8 IDA 4.7 RGD PMID:11090241 RGD:629570 NCBI chr 1:1...65,833,076 JBrowse link
Q Pia9 Pristane induced arthritis QTL 9 IDA 0.048 4.5 RGD PMID:12571866 RGD:629560 NCBI chr 4:80,694,870...125,694,870 JBrowse link
streptococcal cell wall term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Scwia1 Streptococcal cell wall induced arthritis QTL 1 IDA 2.3 RGD PMID:10331011 RGD:61064 NCBI chr 4:106,805,662...151,805,662 JBrowse link
Toxoplasma gondii cysts term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Toxo1 Toxoplasma gondii resistance QTL 1 IDA RGD PMID:16407112 RGD:1578521 NCBI chr10:52,200,030...59,378,278 JBrowse link
Trichinella spiralis larvae term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tspe1 Trichinella spiralis expulsion QTL 1 IDA 4.8 RGD PMID:16465509 RGD:1578305 NCBI chr 9:61,381,434...65,691,299 JBrowse link
type II collagen term browser
Symbol Object Name Evidence rsID P Value LOD Score Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Cia1 Collagen induced arthritis QTL 1 IDA RGD PMID:8782824 RGD:61062 NCBI chr20:3,621,656...14,101,050 JBrowse link
Q Cia10 Collagen induced arthritis QTL 10 IDA 3.4 RGD PMID:9870869 RGD:61063 NCBI chr 2:179,946,951...224,946,951 JBrowse link
Q Cia11 Collagen induced arthritis QTL 11 IDA 5.6 RGD PMID:10857786 RGD:61066 NCBI chr 3:30,356,773...98,535,386 JBrowse link
Q Cia12 Collagen induced arthritis QTL 12 IDA 4.6 RGD PMID:10857786 RGD:61066 NCBI chr12:13,635,523...35,682,913 JBrowse link
Q Cia13 Collagen induced arthritis QTL 13 IDA 4.5 RGD PMID:11001927 RGD:61067 NCBI chr 4:132,642,577...167,139,601 JBrowse link
Q Cia14 Collagen induced arthritis QTL 14 IDA 3.0 RGD PMID:10857786 RGD:61066 NCBI chr19:10,827,970...43,544,039 JBrowse link
Q Cia15 Collagen induced arthritis QTL 15 IDA 4.6 RGD PMID:11001927 RGD:61067 NCBI chr 9:5,109,826...42,921,101 JBrowse link
Q Cia16 Collagen induced arthritis QTL 16 IDA 3.2 RGD PMID:11001927 RGD:61067 NCBI chr10:6,357,896...96,121,100 JBrowse link
Q Cia17 Collagen induced arthritis QTL 17 IDA 4.6 RGD PMID:11001927 RGD:61067 NCBI chr18:31,359,408...70,263,868 JBrowse link
Q Cia18 Collagen induced arthritis QTL 18 IDA 3.1 RGD PMID:11001927 RGD:61067 NCBI chr  X:14,843,113...120,568,734 JBrowse link
Q Cia19 Collagen induced arthritis QTL 19 IDA 4.4 RGD PMID:11001927 RGD:61067 NCBI chr  X:65,612,192...120,568,734 JBrowse link
Q Cia2 Collagen induced arthritis QTL 2 IDA 5.0 RGD PMID:8782824 RGD:61062 NCBI chr 1:78,430,754...91,209,302 JBrowse link
Q Cia20 Collagen induced arthritis QTL 20 IDA 3.2 RGD PMID:11003387 RGD:631168 NCBI chr10:23,444,813...104,060,283 JBrowse link
Q Cia21 Collagen induced arthritis QTL 21 IDA 3.1 RGD PMID:11003387 RGD:631168 NCBI chr10:14,487,011...104,060,283 JBrowse link
Q Cia22 Collagen induced arthritis QTL 22 IDA 8.9 RGD PMID:11003387 RGD:631168 NCBI chr10:40,035,094...104,060,283 JBrowse link
Q Cia23 Collagen induced arthritis QTL 23 IDA 3.9 RGD PMID:11003387 RGD:631168 NCBI chr10:40,035,094...104,060,283 JBrowse link
Q Cia24 Collagen induced arthritis QTL 24 IDA 4.5 RGD PMID:10857786 RGD:61066 NCBI chr 4:146,565,735...175,236,377 JBrowse link
Q Cia25 Collagen induced arthritis QTL 25 IDA 4.7 RGD PMID:15334486 RGD:1285224 NCBI chr12:19,610,889...35,682,913 JBrowse link
Q Cia26 Collagen induced arthritis QTL 26 IDA 3.6 RGD PMID:15334486 RGD:1285224 NCBI chr18:54,709,769...83,828,827 JBrowse link
Q Cia27 Collagen induced arthritis QTL 27 IDA 0.0045 2.6 RGD PMID:9870869 RGD:61063 NCBI chr10:76,452,683...107,211,142 JBrowse link
Q Cia28 Collagen induced arthritis QTL 28 IDA RGD PMID:15944295 RGD:1359065 NCBI chr10:96,120,911...104,060,283 JBrowse link
Q Cia29 Collagen induced arthritis QTL 29 IDA RGD PMID:15944295 RGD:1359065 NCBI chr10:33,973,921...78,973,921 JBrowse link
Q Cia3 Collagen induced arthritis QTL 3 IDA 4.8 RGD PMID:8782824 RGD:61062 NCBI chr 4:103,194,656...148,194,656 JBrowse link
Q Cia4 Collagen induced arthritis QTL 4 IDA 5.3 RGD PMID:8782824 RGD:61062 NCBI chr 7:58,113,224...62,004,598 JBrowse link
Q Cia5 Collagen induced arthritis QTL 5 IDA 4.9 RGD PMID:8782824 RGD:61062 NCBI chr10:91,228,102...104,060,283 JBrowse link
Q Cia6 Collagen induced arthritis QTL 6 IDA RGD PMID:11001927 RGD:61067 NCBI chr 8:82,460,758...122,812,818 JBrowse link
Q Cia7 Collagen induced arthritis QTL 7 IDA 1.0E-4 4.6 RGD PMID:11001927 RGD:61067 NCBI chr 2:59,324,377...141,596,857 JBrowse link
Q Cia8 Collagen induced arthritis QTL 8 IDA 5.1 RGD PMID:10398805 RGD:61069
Q Cia9 Collagen induced arthritis QTL 9 IDA RGD PMID:9870869 RGD:61063
Q Ciaa1 CIA Autoantibody QTL 1 IDA 0.001 30.0 RGD PMID:11001927 RGD:61067 NCBI chr20:2,646,395...4,597,031 JBrowse link
Q Ciaa2 CIA Autoantibody QTL 2 IDA 7.1 RGD PMID:10857786 RGD:61066 NCBI chr10:63,221,094...107,211,142 JBrowse link
Q Ciaa3 CIA Autoantibody QTL 3 IDA 6.5 RGD PMID:10857786 RGD:61066 NCBI chr 9:7,954,720...22,071,169 JBrowse link
Q Ciaa4 CIA Autoantibody QTL 4 IDA 3.1 RGD PMID:11001927 RGD:61067 NCBI chr 4:126,395,976...167,139,601 JBrowse link
Q Ciaa5 CIA Autoantibody QTL 5 IDA 3.5 RGD PMID:11001927 RGD:61067 NCBI chr 5:94,858,972...143,070,159 JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  experimental condition 2376
    disease-inducing agent 223
      arthritis-inducing agent + 113
      cancer cells + 0
      disease-inducing chemical + 209
      glomerulonephritis-inducing agent + 1
      intracerebral hemorrhage induced by collagenase injection 0
      pathogen + 12
paths to the root